Merrimack Pharmaceuticals, Inc. (MACK): Price and Financial Metrics
GET POWR RATINGS... FREE!
MACK Stock Price Chart Interactive Chart >
MACK Price/Volume Stats
|Current price||$5.25||52-week high||$7.41|
|Prev. close||$5.25||52-week low||$3.66|
|Day high||$5.80||Avg. volume||34,970|
|50-day MA||$5.92||Dividend yield||N/A|
|200-day MA||$5.05||Market Cap||70.40M|
Merrimack Pharmaceuticals, Inc. (MACK) Company Bio
Merrimack Pharmaceuticals is a biopharmaceutical company discovering, developing and preparing to commercialize innovative medicines paired with companion diagnostics for the treatment of cancer. The company was founded in 1993 and is based in Cambridge, Massachusetts.
Most Popular Stories View All
MACK Latest News Stream
|Loading, please wait...|
MACK Latest Social Stream
View Full MACK Social Stream
Latest MACK News From Around the Web
Below are the latest news stories about Merrimack Pharmaceuticals Inc that investors may wish to consider to help them evaluate MACK as an investment opportunity.
Insider Buying: The Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) Co-Founder & Independent Director Just Bought 63% More Shares
Even if it's not a huge purchase, we think it was good to see that Ulrik Nielsen, the Co-Founder & Independent Director...
Here's Why We're Not At All Concerned With Merrimack Pharmaceuticals' (NASDAQ:MACK) Cash Burn Situation
We can readily understand why investors are attracted to unprofitable companies. For example, although...
CAMBRIDGE, Mass., November 04, 2021--Merrimack Pharmaceuticals Reports Third Quarter 2021 Financial Results
Looking at Merrimack Pharmaceuticals, Inc.'s ( NASDAQ:MACK ) insider transactions over the last year, we can see that...
CAMBRIDGE, Mass., August 05, 2021--Merrimack Pharmaceuticals, Inc. (Nasdaq:MACK) ("Merrimack" or the "Company") today announced its second quarter 2021 financial results for the period ended June 30, 2021.
MACK Price Returns